Sangam: A Confluence of Knowledge Streams

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial

Files in this item

Files Size Format View
PIIS0923753420398379.pdf 502.9Kb application/pdf View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse